The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern

Diabetic retinopathy (DR) is a prevalent complication of diabetes, significantly impacting patients’ quality of life due to vision loss. No pharmacological therapies are currently approved for DR, excepted the drugs to treat diabetic macular edema such as the anti-VEGF agents or steroids administere...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wen-Jie, An, Xue-Dong, Zhang, Yue-Hong, Zhao, Xue-Fei, Sun, Yu-Ting, Yang, Cun-Qing, Kang, Xiao-Min, Jiang, Lin-Lin, Ji, Hang-Yu, Lian, Feng-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680169/
https://www.ncbi.nlm.nih.gov/pubmed/38027131
http://dx.doi.org/10.3389/fendo.2023.1270145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680169/
https://www.ncbi.nlm.nih.gov/pubmed/38027131
http://dx.doi.org/10.3389/fendo.2023.1270145

Ejemplares similares